Female Urogenital Diseases D052776

Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases

Description

Pathological processes of the female URINARY TRACT and the reproductive system (GENITALIA, FEMALE).   MeSH

Hierarchy View

Subtype Terms (6)

Genital Diseases, Female
42 drugs (39 approved, 3 experimental)

Pelvic Floor Disorders
11 drugs (10 approved, 1 experimental)

Tuberculosis, Urogenital
 

Urogenital Abnormalities
3 drugs (2 approved, 1 experimental)

Urogenital Neoplasms
41 drugs (25 approved, 16 experimental)

Urologic Diseases
48 drugs (36 approved, 12 experimental)


Approved Indicated Drugs (1)

Phase 4 Indicated Drugs (4)

Phase 2 Indicated Drugs (2)

Phase 1 Indicated Drugs (2)

Other Experimental Indicated Drugs (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.